Peripheral Administration of Nitroglycerin in Pulseless Ventricular Tachycardia due to Cocaine-Induced Coronary Vasospasm

Cardiovascular Toxicology - Tập 21 - Trang 490-493 - 2021
Savalan Babapoor-Farrokhran1, Aditi Kalla1, Deanna Gill2, Asma Gulab3, Sahil Banka1, Sanjog Kalra1
1Division of Cardiology, Department of Medicine, Einstein Medical Center, Philadelphia, USA
2Department of Medicine, Emory University School of Medicine, Atlanta, USA
3Department of Medicine, Einstein Medical Center, Philadelphia, USA

Tóm tắt

Cocaine use accounts for 40% of the annual drug use related emergency department visits in the United States. Cocaine use is hence recognized as a major health problem. Cocaine blocks the presynaptic reuptake of norepinephrine and dopamine. The resulting increased adrenergic activity leads to vasoconstriction. Additionally, via various mechanisms, cocaine leads to a prothrombotic state and increases myocardial demand. Cocaine can cause coronary vasospasm and is therefore, associated with acute myocardial injury even in the absence of pre-existing atherosclerotic coronary artery disease. Nitroglycerin has a class 1C indication by the ACCF/AHA guidelines for patients with ST-segment elevation or depression that accompanies ischemic chest discomfort in the setting of cocaine use. It has been shown to reverse cocaine-induced coronary vasospasm and chest pain. In this case report, for the first time, we discuss how intravenous administration of high dose nitroglycerin to a patient in pulseless ventricular tachycardia with angiographically confirmed vasospasm induced by cocaine resulted in return of spontaneous circulation.

Tài liệu tham khảo

Substance Abuse and Mental Health Services Administration. DAWN 2011 Emergency Department Data. (n.d.), Available at: https://www.samhsa.gov/data/sites/de. Mittleman, M. A., Mintzer, D., Maclure, M., Tofler, G. H., Sherwood, J. B., & Muller, J. E. (1999). Triggering of myocardial infarction by cocaine. Circulation, 99(21), 2737–2741. https://doi.org/10.1161/01.CIR.99.21.2737. Brogan, W. C., Lange, R. A., Glamann, D. B., & Hillis, L. D. (1992). Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Annals of Internal Medicine, 116(7), 556–561. https://doi.org/10.7326/0003-4819-116-7-556. Brogan, W. C., Lange, R. A., Kim, A. S., Moliterno, D. J., & Hillis, L. D. (1991). Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. Journal of the American College of Cardiology, 18(2), 581–586. https://doi.org/10.1016/0735-1097(91)90617-I. Weiss, R. D., & Gawin, F. H. (1988). Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers. The American Journal of Medicine, 85(6), 879–880. https://doi.org/10.1016/S0002-9343(88)80042-1. Mena, I., Giombetti, R. J., Miller, B. L., Garrett, K., Villanueva-Meyer, J., Mody, C., & Goldberg, M. A. (1994). Cerebral blood flow changes with acute cocaine intoxication: Clinical correlations with SPECT, CT, and MRI. In NIDA Research Monograph Series (pp. 161–173). National Institute on Drug Abuse. Retrieved from https://researchexperts.utmb.edu/en/publications/cerebral-blood-flow-changes-with-acute-cocaine-intoxication-clini Smith, M. L., Shimomura, E., Paul, B. D., Cone, E. J., Darwin, W. D., & Huestis, M. A. (2010). Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. Journal of Analytical Toxicology, 34(2), 57–63. https://doi.org/10.1093/jat/34.2.57. Cone, E. J., Sampson-Cone, A. H., Darwin, W. D., Huestis, M. A., & Oyler, J. M. (2003). Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. Journal of Analytical Toxicology, 27(7), 386–401. https://doi.org/10.1093/jat/27.7.386. Colucci, W. S., Elkayam, U., Horton, D. P., Abraham, W. T., Bourge, R. C., Johnson, A. D., & LeJemtel, T. H. (2000). Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. New England Journal of Medicine, 343(4), 246–253. https://doi.org/10.1056/nejm200007273430403.